New Funding Opportunities
This page is updated as new funding opportunities are announced.
Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) (R01)
(RFA-GM-10-009)
Application Due Date(s): November 24, 2009
Purpose: This FOA solicits Research Project Grant (R01) applications from institutions/organizations proposing exceptionally innovative research on novel hypotheses or difficult problems, solutions to which would have an extremely high impact on biomedical or biobehavioral research that is germane to the mission of one or more of the participating NIH Institutes. [Read more]
RECOVERY: R&D on Human Biospecimen Integrity (Contracts)
(ST10-1005)
Application Due Date(s): Dec 14, 2009
Program Objectives: The Biospecimen Research Network seeks proposals that will significantly advance the field of biospecimen science. [Read more]
Roadmap Transformative Research Projects Program (R01)
(RFA-RM-09-022)
Application Due Date(s): January 22, 2010
Purpose: As part of the NIH Roadmap for Biomedical Research, the National Institutes of Health invites transformative Research Project Grant (R01) applications from institutions/organizations proposing groundbreaking, exceptionally innovative, high risk, original and/or unconventional research with the potential to create new scientific paradigms or challenge existing ones. [Read more]
Innovative Technology Development for Cancer Research (R21)
(RFA-CA-10-005)
Application Due Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Purpose: This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of cancer-relevant technologies. [Read more]
Application and Early Stage Development of Emerging Technologies in Cancer Research (R21)
(RFA-CA-10-003)
Application Due Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications that propose exploratory research projects on the initial application of emerging analytical technologies as laboratory or clinical tools. [Read more]
Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
(RFA-CA-10-004)
Application Due Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system. [Read more]
Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21)
(RFA-CA-10-001)
Application Due Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of cancer-relevant technologies that address the issues related to pre-analytical variations in the collection, processing, handling, and storage of biospecimens or its derivatives. [Read more]
Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)
(RFA-CA-10-002)
Application Due Date(s): February 23, 2010; May 27, 2010; September 30, 2010
Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing technically innovative feasibility studies focused on the advanced development and validation of cancer-relevant technologies that address the issues related to pre-analytical variations in the collection, processing, handling, and storage of biospecimens or its derivatives. [Read more]
Bioengineering Research Grants (BRG)(R01)
(PA-07-279)
Application Due Date(s): March 5, 2010; July 5, 2010; November 5, 2010
Purpose: Participating Institutes and Centers of the NIH invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. [Read more]
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)
(PA-06-418)
Application Due Date(s): March 16, 2010; July 16, 2010; November 16, 2010
Research Objectives: Solicited here, under the auspices of Bioengineering Consortium (BECON), are applications for exploratory or developmental bioengineering research grants (EBRG) that serve the mission of one or more of the participating NIH institutes or centers. The EBRG can support: 1) innovative, high-risk, high pay-off projects; 2) exploration of new approaches or concepts to a particular substantive area; 3) research and development of new technologies, techniques or methods; or 4) initial research and development of data upon which significant future research may be built. [Read more]
